Announcements Trials

Browse Landscape

Phase

Status

Recruiting 6 Not yet recruiting 3 Unknown 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 6 Carcinoma, Hepatocellular 6 Esophageal Squamous Cell Carcinoma 5 Esophageal Neoplasms 3 Advanced Solid Tumor 3 Stomach Neoplasms 2 Lung Neoplasms 2 Cholangiocarcinoma 2 Advanced Lung Cancer 2 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Squamous NSCLC 1 Solid Tumor 1 SCLC 1 Recurrence 1 Rectal Neoplasms 1 Ovarian Neoplasms 1 Non-Squamous Non-Small Cell Lung Cancer 1 Neoplasms, Unknown Primary 1 Neoplasms, Squamous Cell 1 Neoplasms 1 Neoplasm Metastasis 1 Locally Advanced Rectal Cancer 1 Liver Neoplasms 1 Liver Diseases 1 High-Risk Resectable NSCLC 1 Gastrointestinal Diseases 1 Esophageal Diseases 1 Endometrial Neoplasms 1 Colorectal Neoplasms 1

Interventions

Fluorouracil 155 Oxaliplatin 133 Leucovorin 124 Capecitabine 90 Irinotecan 88 Radiotherapy 63 Bevacizumab 61 Cetuximab 38 Folfox protocol 25 Panitumumab 21 Neoadjuvant Therapy 21 Surgical Procedures, Operative 19 Chemotherapy, Adjuvant 15 Radiation 13 Floxuridine 13 Erlotinib Hydrochloride 13 Early Intervention, Educational 13 IFL protocol 11 Drug Therapy 11 Proctectomy 10 Magnetic Resonance Spectroscopy 10 Counseling 10 Surveys and Questionnaires 8 Sorafenib 8 Psychiatric Rehabilitation 8 Gene Expression Profiling 8 Radiotherapy, Intensity-Modulated 7 Immunohistochemistry 7 Gemcitabine 7 Celecoxib 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Rectal Neoplasms × sintilimab × Clear all

NCT06108596 2025-01-21

PICS

The First Affiliated Hospital with Nanjing Medical University

Phase 2 Completed

Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡